We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Magna International
MGA
$18.9B
| $115K | ﹤0.01% |
+2,040
| New | +$115K |
|
1127
KB Financial Group
KB
$40.6B
| $113K | ﹤0.01% |
+2,930
| New | +$106K |
|
1128
Coupang
CPNG
$27.8B
| $112K | ﹤0.01% |
+7,636
| New | +$135K |
|
1129
MetLife
MET
$62.6B
| $110K | ﹤0.01% |
1,521
+154
| +11% | +$11K |
|
1130
ResMed
RMD
$30.3B
| $109K | ﹤0.01% |
524
-2,314
| -82% | -$508K |
|
1131
Clorox
CLX
$12.1B
| $108K | ﹤0.01% |
773
-9,778
| -93% | -$1.39M |
|
1132
Check Point Software Technologies
CHKP
$14.1B
| $107K | ﹤0.01% |
846
+761
| +895% | +$95K |
|
1133
Lincoln National
LNC
$8.14B
| $106K | ﹤0.01% |
3,456
-197,414
| -98% | -$7.84M |
|
1134
DaVita
DVA
$15.5B
| $106K | ﹤0.01% |
1,416
-6,413
| -82% | -$498K |
|
1135
Moody's
MCO
$83.7B
| $101K | ﹤0.01% |
363
+41
| +13% | +$11.2K |
|
1136
Waters Corp
WAT
$38B
| $101K | ﹤0.01% |
295
-1,841
| -86% | -$582K |
|
1137
BCE
BCE
$20.3B
| $99.1K | ﹤0.01% |
+2,255
| New | +$102K |
|
1138
Zimmer Biomet
ZBH
$18.5B
| $96.6K | ﹤0.01% |
758
-4,895
| -87% | -$568K |
|
1139
Nice
NICE
$5.88B
| $93.3K | ﹤0.01% |
+485
| New | +$93.4K |
|
1140
Baxter International
BAX
$12.6B
| $92.6K | ﹤0.01% |
1,817
-22,538
| -93% | -$1.21M |
|
1141
Simon Property Group
SPG
$76.7B
| $88.6K | ﹤0.01% |
754
-6,378
| -89% | -$709K |
|
1142
Grupo Aeroportuario del Sureste
ASR
$8.09B
| $84.8K | ﹤0.01% |
+364
| New | +$84.6K |
|
1143
Prudential Financial
PRU
$42.9B
| $84.5K | ﹤0.01% |
850
+92
| +12% | +$9.32K |
|
1144
Coca-Cola Europacific Partners
CCEP
$49B
| $83.4K | ﹤0.01% |
+1,508
| New | +$75.7K |
|
1145
Spotify
SPOT
$104B
| $83.1K | ﹤0.01% |
+1,053
| New | +$84.9K |
|
1146
Allstate
ALL
$69.7B
| $83K | ﹤0.01% |
612
+61
| +11% | +$7.98K |
|
1147
Brookfield Asset Management
BAM
$76.5B
| $77.6K | ﹤0.01% |
+2,705
| New | +$81.4K |
|
1148
Ameriprise Financial
AMP
$48.3B
| $76.3K | ﹤0.01% |
245
-29,215
| -99% | -$8.91M |
|
1149
Teva Pharmaceuticals
TEVA
$36.8B
| $75.9K | ﹤0.01% |
+8,318
| New | +$72.6K |
|
1150
VICI Properties
VICI
$29.8B
| $72K | ﹤0.01% |
2,223
+261
| +13% | +$8.38K |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.